From the, Division of Hematology, Mayo Clinic, Rochester, MN, USA.
Hematology Institute, Chaim Sheba Medical Center, Tel Hashomer, Israel.
J Intern Med. 2021 Mar;289(3):268-292. doi: 10.1111/joim.13169. Epub 2020 Sep 14.
Systemic amyloidosis is a rare protein misfolding and deposition disorder leading to progressive organ failure. There are over 15 types of systemic amyloidosis, each caused by a different precursor protein which promotes amyloid formation and tissue deposition. Amyloidosis can be acquired or hereditary and can affect various organs, including the heart, kidneys, liver, nerves, gastrointestinal tract, lungs, muscles, skin and soft tissues. Symptoms are usually insidious and nonspecific resulting in diagnostic delay. The field of amyloidosis has seen significant improvements over the past decade in diagnostic accuracy, prognosis prediction and management. The advent of mass spectrometry-based shotgun proteomics has revolutionized amyloid typing and has led to the discovery of new amyloid types. Accurate typing of the precursor protein is of paramount importance as the type dictates a specific management approach. In this article, we review each type of systemic amyloidosis to provide the practitioner with practical tools to improve diagnosis and management of these rare disorders.
系统性淀粉样变性是一种罕见的蛋白质错误折叠和沉积疾病,可导致进行性器官衰竭。有超过 15 种系统性淀粉样变性,每种都由不同的前体蛋白引起,这些前体蛋白可促进淀粉样蛋白形成和组织沉积。淀粉样变性可以是获得性的,也可以是遗传性的,可影响包括心脏、肾脏、肝脏、神经、胃肠道、肺、肌肉、皮肤和软组织在内的各种器官。症状通常隐匿且无特异性,导致诊断延迟。在过去十年中,淀粉样变性领域在诊断准确性、预后预测和管理方面取得了重大进展。基于质谱的鸟枪法蛋白质组学的出现彻底改变了淀粉样蛋白分型,并发现了新的淀粉样蛋白类型。准确鉴定前体蛋白至关重要,因为该类型决定了特定的管理方法。本文综述了每种系统性淀粉样变性,为临床医生提供了实用工具,以改善这些罕见疾病的诊断和管理。